Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
Lamotrigine has emerged with a distinct place in the pharmacological treatment of bipolar disorder, with the potential to treat and prevent bipolar depression, which is the dominant and arguably most disabling and under-treated phase of the illness. Bipolar disorder (BD) Four DB-RCTs investigating the efficacy of gabapentin in BD were identified. 101 patients were randomised to receive gabapentin, 81 to placebo, 30 to lamotrigine and 19 to Bipolar disorder is characterized by extreme mood fluctuations, including mania, hypomania, depression, and mixed episodes. Extrapolation of postulated mechanisms of anticonvulsant activity in bipolar disorder has led to the use of the newer anticonvulsants gabapentin and lamotrigine for therapy. For the prophylaxis of bipolar disorder, lithium is still the treatment of choice. Carbamazepine and valproate are good alternatives, especially for patients not responding to lithium or not tolerating it. Lamotrigine may be a good alternative in bipolar depression. The utility of gabapentin and lamotrigine for the treatment of bipolar disorder is reviewed. Bipolar disorder is characterized by extreme mood fluctuations, including mania, hypomania, depression, and mixed episodes. Bipolar disorder is a mental health condition characterized by extreme shifts in mood, concentration, and energy levels. For treatment, healthcare professionals often prescribe a combination of medications, including mood stabilizers and antipsychotics. In recent years, alternative medications like anticonvulsants and calcium channel blockers for bipolar disorder have also been explored. Here Abstract Lamotrigine has emerged with a distinct place in the pharmacological treatment of bipolar disorder, with the potential to treat and prevent bipolar depression, which is the dominant and arguably most disabling and under-treated phase of the illness. This review examines the published clinical trials of lamotrigine in bipolar treatment. After receiving gabapentin 600–3,600 mg/d for 10 weeks, mood scale scores were no different between treatment groups. 19 In a double-blind, randomized, crossover series (N = 31), 20 patients with refractory bipolar and unipolar mood disorder received three 6-week monotherapy treatments of lamotrigine, gabapentin, or placebo. Bipolar disorder is characterized by extreme mood fluctuations, including mania, hypomania, depression, and mixed episodes. Extrapolation of postulated mechanisms of anticonvulsant activity in bipolar disorder has led to the use of the newer anticonvulsants gabapentin and lamotrigine for therapy. Lamotrigine: Despite the recent ap-proval of lamotrigine for the treatment of bipolar disorder, there are very few studies of its combination with other approved agents, such as lithium, di-valproex, and atypical antipsychotics. Combination pharmacotherapy for bipolar disorder is commonplace and often reflects the severity and complexity of the illness and the comorbid conditions frequently associated with it. Across treatment settings, about one-fifth of patients with bipolar disorder appear to receive four or more psychotropic medications. Practice patterns often outpace the evidence-based literature, insofar as few Certain anticonvulsants, in particular valproate and carbamazepine, that were initially used to treat epilepsy have subsequently been found to be effective in the treatment of psychiatric disorders, especially bipolar disorder. Gabapentin and lamotrigine are two new anticonvulsants that appear to have mood stabilizing properties. The authors review the pharmacology, pharmacokinetics, and I have been using Gabapentin and Lamictal for about six years to manage my Bi-Polar type 1 disorder and it works better than any meds or combination of meds I have used in 20 years. It is the longest period of time I have been stable and not had to be hospitalized. Is anyone else using these meds to treat Bi-Polar Disorder? Two new anticonvulsants, lamotrigine and gabapentin, have been used increasingly for bipolar disorder in the past several years. Despite this array of options, bipolar disorder remains a difficult disorder to treat. Some subtypes, such as those characterized by rapid cycling or mixed episodes, have been especially resistant to lithium treatment. The anticonvulsants carbamazepine and sodium valproate have efficacy in hypomania, bipolar depression and in the prophylaxis of bipolar disorder. This paper reviews published evidence on the effects of the new anticonvulsants gabapentin and lamotrigine in bipolar disorder. Certain anticonvulsants, in particular valproate and carbamazepine, that were initially used to treat epilepsy have subsequently been found to be effective in the treatment of psychiatric disorders, especially bipolar disorder. Gabapentin and lamotrigine are two new anticonvulsants that appear to have mood stabilizing properties. The authors review the pharmacology, pharmacokinetics, and Gabapentin demonstrates promise for the treatment of panic and generalized anxiety, while both gabapentin and lamotrigine appear useful as mood stabilizers in the treatment of bipolar disorder. Despite its prevalence and disease burden, several chasms still exist with regard to the pharmacotherapy of bipolar disorder (BD). Polypharmacy is commonly encountered as a significant proportion of patients remain symptomatic, and the management of the depressive phase of the illness is a particular challenge. Gabapentin and pregabalin have often been prescribed off-label in spite of a When it comes to choosing between Lamotrigine and Gabapentin for treating various conditions, one key factor to consider is the efficiency of these medications. Lamotrigine, a medication primarily used to treat epilepsy and bipolar disorder, has been found to be highly efficient in managing seizures and mood swings. Its efficiency lies in its ability to stabilize the electrical activity in the Flowchart of included and excluded studies. Bipolar disorder (BD) Four DB-RCTs investigating the efficacy of gabapentin in BD were identified. 101 patients were randomised to receive gabapentin, 81 to placebo, 30 to lamotrigine and 19 to carbamazepine. The mean age of all randomised patients was 37.5 years and 64.1% were female. Acute treatment Three studies compared gabapentin with three
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |